東方甄選(01797.HK)曾跌8% 公司指堅守產品路線以回應近期風波
東方甄選(01797.HK)今日高開0.54%,早段曾升1%,但隨即掉頭向下,低見25.5元,跌8.3%,見半年新低。現報26.25元,跌5.58%,成交1,970.45萬股,涉資5.19億元。
公司因近日的「小作文」風波股價下跌,內地傳媒引述公司相關負責人表示,近期輿論的爆發,顯示在網紅模式和產品路線兩種模式之間的衡突,公司堅守產品路線,是回應質疑的最好選擇。據公司披露的數據,昨日(14日),東方甄選銷售自營產品的抖音店舖,日銷售額超過6,200萬元人民幣,創過去兩年東方甄選自營品最高銷售紀錄。(cy/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.